Overview

Preservative-free Tafluprost Eye Drops in Newly Diagnosed Patients With Glaucoma

Status:
Completed
Trial end date:
2020-06-01
Target enrollment:
Participant gender:
Summary
Glaucoma encompasses a collective group of optic neuropathies characterized by progressive degeneration of retinal ganglion cells and their axons, resulting in cupping, a distinctive appearance of the optic disc, and a pattern of visual loss
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Alexandria University
Treatments:
Ophthalmic Solutions